Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Tocilizumab in COVID-19 – A Bayesian reanalysis of RECOVERY

View ORCID ProfileArthur M. Albuquerque, View ORCID ProfileLucas Tramujas, View ORCID ProfileLorenzo R. Sewanan, View ORCID ProfileJames M. Brophy
doi: https://doi.org/10.1101/2021.06.15.21258966
Arthur M. Albuquerque
1School of Medicine, Universidade Federal do Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arthur M. Albuquerque
Lucas Tramujas
2HCor Research Institute, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucas Tramujas
Lorenzo R. Sewanan
3Department of Internal Medicine, Columbia University, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorenzo R. Sewanan
James M. Brophy
4McGill University Health Center, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James M. Brophy
  • For correspondence: james.brophy@mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.06.15.21258966
History 
  • June 21, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Arthur M. Albuquerque1,
  2. Lucas Tramujas2,
  3. Lorenzo R. Sewanan3 and
  4. James M. Brophy4,*
  1. 1School of Medicine, Universidade Federal do Rio de Janeiro, Brazil
  2. 2HCor Research Institute, Brazil
  3. 3Department of Internal Medicine, Columbia University, U.S.A.
  4. 4McGill University Health Center, Canada
  1. ↵*Corresponding author:
    James M. Brophy; @brophyj; james.brophy{at}mcgill.ca
  1. Contributorship statements: AMA conceived the study, wrote the protocol, collected the data, wrote the statistical code, interpreted the findings, and wrote the manuscript. LT collected the data, interpreted the findings, and wrote the manuscript. LRS collected the data and critically revised the manuscript. JMB revised the protocol and the statistical code, interpreted the findings, and wrote the manuscript.

Back to top
PreviousNext
Posted June 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tocilizumab in COVID-19 – A Bayesian reanalysis of RECOVERY
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tocilizumab in COVID-19 – A Bayesian reanalysis of RECOVERY
Arthur M. Albuquerque, Lucas Tramujas, Lorenzo R. Sewanan, James M. Brophy
medRxiv 2021.06.15.21258966; doi: https://doi.org/10.1101/2021.06.15.21258966
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Tocilizumab in COVID-19 – A Bayesian reanalysis of RECOVERY
Arthur M. Albuquerque, Lucas Tramujas, Lorenzo R. Sewanan, James M. Brophy
medRxiv 2021.06.15.21258966; doi: https://doi.org/10.1101/2021.06.15.21258966

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9755)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (221)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (425)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)